Skip to main content
. 2024 Sep 16;14:21579. doi: 10.1038/s41598-024-70321-w

Figure 1.

Figure 1

Pairs of representative compounds extracted from AI patents (right) and corresponding prior patents (left) for clinical-stage programs (CDK792,93, A2Ar-antagonist94,95, MALT196,97, QPCTL98,99, USP1100,101, and 3CLpro102,103). The identical atoms between the chemical structures are highlighted in red.